血清合肽素對呼吸衰竭患者預(yù)后評估的臨床意義
發(fā)布時間:2018-12-21 16:24
【摘要】:目的探討合肽素水平對呼吸衰竭患者預(yù)后的臨床意義,以更好地開展治療工作。方法選取2010年12月—2012年12月吉林省前衛(wèi)醫(yī)院呼吸科和吉林大學(xué)第一醫(yī)院急診科重癥監(jiān)護室收治的132例呼吸衰竭患者,檢測患者入院時的血清合肽素水平,并記錄各項實驗室檢測指標和臨床生理指標。以28 d為終點比較存活組與死亡組患者的合肽素水平、急性生理學(xué)與慢性健康狀況評分系統(tǒng)Ⅱ(APACHEⅡ)評分和簡化急性生理學(xué)評分系統(tǒng)Ⅱ(SAPSⅡ)評分;分析合肽素水平與28 d病死率的關(guān)系。結(jié)果 132例呼吸衰竭患者28 d內(nèi)共有41例病死,死亡組血清合肽素水平高于存活組,差異有統(tǒng)計學(xué)意義〔(44.5±9.0)pmol/L比(29.2±12.0)pmol/L,P0.01〕。合肽素水平與APACHEⅡ評分和SAPSⅡ評分均呈正相關(guān)(r值分別為0.562、0.550)。合肽素水平預(yù)測28 d病死率的受試者工作特征曲線(ROC曲線)下面積為0.840〔95%CI(0.772,0.907)〕,預(yù)測28 d病死率的最佳界值為34.5 pmol/L。血清合肽素34.5 pmol/L、APACHEⅡ評分17.5分和SAPSⅡ評分30.5分是預(yù)測呼吸衰竭患者28 d病死率的獨立危險因素。結(jié)論合肽素水平是預(yù)測呼吸衰竭患者28 d病死率的獨立指標,其預(yù)測能力與APACHEⅡ評分和SAPSⅡ評分相近。
[Abstract]:Objective to investigate the clinical significance of peptide level in the prognosis of patients with respiratory failure. Methods from December 2010 to December 2012, 132 patients with respiratory failure were selected from Department of Respiratory, Department of Respiratory and Emergency Department, first Hospital of Jilin University. The laboratory indexes and clinical physiological indexes were recorded. At the end of 28 days, the levels of synpeptidin, acute physiology and chronic health status scoring system 鈪,
本文編號:2389154
[Abstract]:Objective to investigate the clinical significance of peptide level in the prognosis of patients with respiratory failure. Methods from December 2010 to December 2012, 132 patients with respiratory failure were selected from Department of Respiratory, Department of Respiratory and Emergency Department, first Hospital of Jilin University. The laboratory indexes and clinical physiological indexes were recorded. At the end of 28 days, the levels of synpeptidin, acute physiology and chronic health status scoring system 鈪,
本文編號:2389154
本文鏈接:http://www.sikaile.net/yixuelunwen/huxijib/2389154.html
最近更新
教材專著